logo
Plus   Neg
Share
Email

Dr. Reddy's Partners With FUJIFILM, Global Response Aid For Avigan Tablets - Quick Facts

Dr. Reddy's Laboratories Ltd. (RDY) said it partnered with FUJIFILM Corporation through FUJIFILM Toyama Chemical Co. Ltd. and Global Response Aid for the development, manufacture and sales of Avigan Tablets, a potential treatment of COVID-19.

Under the tripartite agreement signed on 30th June 2020, FUJIFILM granted Dr. Reddy's the exclusive rights of manufacturing and also granted both Dr. Reddy's and GRA the rights to develop, sell and distribute Avigan in all countries other than Japan, China and Russia.

Dr. Reddy noted that it would have exclusive rights for development, selling and distribution of Avigan in India. Further, FUJIFILM would receive an upfront license fee and royalties on sales from Dr. Reddy's and GRA.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT